FI970786L - 4-/2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena - Google Patents

4-/2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena Download PDF

Info

Publication number
FI970786L
FI970786L FI970786A FI970786A FI970786L FI 970786 L FI970786 L FI 970786L FI 970786 A FI970786 A FI 970786A FI 970786 A FI970786 A FI 970786A FI 970786 L FI970786 L FI 970786L
Authority
FI
Finland
Prior art keywords
purin
cyclopropylamino
cyclopentene
amino
antiviral agent
Prior art date
Application number
FI970786A
Other languages
English (en)
Swedish (sv)
Other versions
FI970786A0 (fi
FI120403B (fi
Inventor
Susan Mary Daluge
Jeffrey Douglas Wilson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI970786A0 publication Critical patent/FI970786A0/fi
Publication of FI970786L publication Critical patent/FI970786L/fi
Application granted granted Critical
Publication of FI120403B publication Critical patent/FI120403B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
FI970786A 1994-08-26 1997-02-25 4-(2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena FI120403B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9417249A GB9417249D0 (en) 1994-08-26 1994-08-26 A novel salt
GB9417249 1994-08-26
PCT/GB1995/002014 WO1996006844A1 (en) 1994-08-26 1995-08-25 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent
GB9502014 1995-08-25

Publications (3)

Publication Number Publication Date
FI970786A0 FI970786A0 (fi) 1997-02-25
FI970786L true FI970786L (fi) 1997-02-25
FI120403B FI120403B (fi) 2009-10-15

Family

ID=10760434

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970786A FI120403B (fi) 1994-08-26 1997-02-25 4-(2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena

Country Status (23)

Country Link
EP (1) EP0777669B1 (fi)
JP (1) JPH10505593A (fi)
KR (1) KR100376240B1 (fi)
CN (1) CN1051550C (fi)
AT (1) ATE220067T1 (fi)
AU (1) AU702618B2 (fi)
BR (1) BR9508629A (fi)
CA (1) CA2198010C (fi)
DE (1) DE69527294T2 (fi)
DK (1) DK0777669T3 (fi)
ES (1) ES2179110T3 (fi)
FI (1) FI120403B (fi)
GB (1) GB9417249D0 (fi)
HU (1) HU221302B1 (fi)
IL (1) IL115074A (fi)
MX (1) MX9701273A (fi)
NO (1) NO315200B1 (fi)
NZ (1) NZ291862A (fi)
PT (1) PT777669E (fi)
RU (1) RU2145324C1 (fi)
SI (1) SI0777669T1 (fi)
WO (1) WO1996006844A1 (fi)
ZA (1) ZA957166B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
EP0979082A1 (en) * 1997-05-17 2000-02-16 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
BR9809124A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação, farmacêutica, processo para o tratamento de uma infecção por hiv em um animal, infectado, uso de (-)-(1s, 4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-cicl openteno-1-metanol, e, pacote de paciente
SK284594B6 (sk) * 1997-11-27 2005-07-01 Lonza Ag Spôsob výroby derivátov aminoalkoholov a ich soli
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
GB9918035D0 (en) * 1999-07-30 1999-09-29 Novartis Ag Organic compounds
MXPA02009534A (es) * 2000-03-30 2003-05-14 Squibb Bristol Myers Co Granulos de liberacion sostenida que contienen estavudina.
NZ524252A (en) * 2000-07-20 2004-03-26 Lauras As Cox-2 inhibitors for treating HIV and AIDS
WO2003011221A2 (en) 2001-07-30 2003-02-13 University Of Southern California PREPARATION AND USE OF α-KETO PHOSPHONATES
RU2242243C2 (ru) * 2001-09-27 2004-12-20 Вертелецкий Павел Васильевич Композиции и способы потенцирования терапевтических эффектов интерферонов
CA2543201C (en) * 2003-10-27 2010-12-21 Merck & Co., Inc. ((ir, 3s)-3-isopropyl-3-{ [3-(trifluoromethyl)-7, 8-dihydro-1, 6-naphthyridin-6 (5h)-yl] carbonyl} cyclopentyl) [(3s, 4s)-3-methoxytetrahydro-2h-pyran-4-yl] amine succinate salt, composition thereof, and its use in the treatment of inflammatory diseases
EP1905772A1 (en) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
WO2012137227A2 (en) 2011-04-08 2012-10-11 Laurus Labs Private Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
EP2962693B1 (en) 2013-02-27 2019-01-09 Kyoto University Pharmaceutical composition comprising abacavir for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025492A1 (de) * 1980-07-04 1982-02-04 Siemens AG, 1000 Berlin und 8000 München Filterelement fuer die optische nachrichtentechnik
ZA83626B (en) * 1982-02-01 1983-12-28 Syntex Inc Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent
US5003462A (en) * 1988-05-31 1991-03-26 International Business Machines Corporation Apparatus and method for implementing precise interrupts on a pipelined processor with multiple functional units with separate address translation interrupt means
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Also Published As

Publication number Publication date
DK0777669T3 (da) 2002-10-28
EP0777669A1 (en) 1997-06-11
AU702618B2 (en) 1999-02-25
BR9508629A (pt) 1997-11-25
IL115074A (en) 1998-10-30
ES2179110T3 (es) 2003-01-16
GB9417249D0 (en) 1994-10-19
JPH10505593A (ja) 1998-06-02
NO970847L (no) 1997-02-25
KR970705563A (ko) 1997-10-09
CA2198010A1 (en) 1996-03-07
CA2198010C (en) 2006-05-02
CN1156456A (zh) 1997-08-06
AU3350995A (en) 1996-03-22
PT777669E (pt) 2002-11-29
ZA957166B (en) 1997-02-25
ATE220067T1 (de) 2002-07-15
MX9701273A (es) 1997-05-31
CN1051550C (zh) 2000-04-19
RU2145324C1 (ru) 2000-02-10
IL115074A0 (en) 1995-12-08
NO315200B1 (no) 2003-07-28
NZ291862A (en) 1998-02-26
HU221302B1 (en) 2002-09-28
KR100376240B1 (ko) 2003-06-11
NO970847D0 (no) 1997-02-25
EP0777669B1 (en) 2002-07-03
FI970786A0 (fi) 1997-02-25
FI120403B (fi) 2009-10-15
HUT77222A (hu) 1998-03-02
WO1996006844A1 (en) 1996-03-07
DE69527294D1 (en) 2002-08-08
SI0777669T1 (en) 2002-12-31
DE69527294T2 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
FI970786L (fi) 4-/2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena
FI971413L (fi) Puriini- ja guaniiniyhdisteet PNP:n estäjinä
FI934226L (fi) Foerbaettringar i eller relaterande till kontrastmedel
FI934227L (fi) Foerbaettringar i eller relaterande till kontrastmedel
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
EE04772B1 (et) 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
TR199801367A3 (tr) 5H- tiazol (3,2-a) pirimidin türevleri
FI954404L (fi) Fenoksifenyylietikkahappojohdannaiset
DE69837611D1 (de) Dilatationssysteme
DK0769965T3 (da) Vandige risperidonformuleringer
DE69835418D1 (de) Schaltungsanordnung zum schutz von teilnehmerschnittstellen
PT958282E (pt) 2-amino-6-(2-substituido-4-fenoxi)-substituido-piridinas
DE69219710D1 (de) Saures haarfärbemittel
ID17988A (id) Penggunaan turunan asam piridina tersubstitusi 5-dan heksahidrokuinolina 3-karboksilik
FI963885L (fi) Pyrimidiini- tai triatsiinikarboksyylihappojohdannaiset käytettäväksi lääkaineina
EE9600057A (et) Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks
DE69524611D1 (de) Pyrimidon-derivate
KR960700242A (ko) 8-메톡시퀴놀론카르복실산 유도체(8-methoxyquinolonecarboxylic acid derivative)
FI970195A7 (fi) Trifluormetyylikinoliinikarboksyylihappojohdannainen
FI941064A7 (fi) Asyylioksiheksaanihappojohdannaiset
FI972585L (fi) Virustenvastaisina aineina käyttökelpoiset tienoksatsinonijohdannaiset
FI940040A7 (fi) Nonatetraeenihappojohdannainen
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
GB9926138D0 (en) Diphenylacetic acid derivatives and their use as antiviral agents

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120403

Country of ref document: FI

MA Patent expired